Clinical trials - Press Releases

Date	Title	Company
19-May-2021	Amolyt Pharma to Present New Phase 1 Data on AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, and Preclinical Data on AZP-3404 at Upcoming Scientific Conferences	Amolyt Pharma
19-May-2021	Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials	Sosei Heptares
18-May-2021	Seven key takeaways from joining Aseptic Processing Conference in September 2021	SMi Group
18-May-2021	Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection.	Oxford Immunotec
18-May-2021	Ziltivekimab reduced inflammatory biomarkers associated with atherosclerosis in people with chronic kidney disease in phase 2 trial	Novo Nordisk
18-May-2021	Medicago and GSK announce positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate	Medicago and GSK
17-May-2021	Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research	Agilex Biolabs
17-May-2021	New Data Shows Devastating Impact of AADC Deficiency on Caregivers	PTC Therapeutics, Inc.
13-May-2021	MyMeds&Me and conversationHEALTH announce partnership to revolutionise the virtual interaction between medicines’ providers, patients, and HCPs	MyMeds&Me
13-May-2021	New tezepelumab data continue to strengthen profile for a broad population of severe asthma patients	AstraZeneca and Amgen
13-May-2021	Positive Phase 3 Libtayo® (cemiplimab) results in advanced cervical cancer presented at ESMO Virtual Plenary	Sanofi
13-May-2021	Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data	Biogen
12-May-2021	UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)	Northwest Biotherapeutics
11-May-2021	Gelmetix closes successful £5 million capital raise, progresses to first-in-human trial	Gelmetix
11-May-2021	Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency	Oxford Immunotec
11-May-2021	Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate	Novavax
10-May-2021	Bionomics Expanding BNC210 for Acute Treatment of Social Anxiety Disorder in Addition to Phase 2b Trial for PostTraumatic Stress Disorder	Bionomics
10-May-2021	Global Prils Market is estimated to be US$ 3496.8 million by 2030 with a CAGR of 4.4% during the forecast period	Prophecy Market Insights
07-May-2021	Imfinzi and tremelimumab with chemotherapy demonstrated overall survival benefit in POSEIDON trial for 1st-line Stage IV non-small cell lung cancer	AstraZeneca
06-May-2021	Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern	Moderna